![]() ![]() ![]() Patients for Affordable Drugs’ political arm has not endorsed a candidate in the May 17 primary.Ĭongressman Schrader’s record of delivering results for Oregonians is clear. “He stood with Pharma against the will of voters who overwhelmingly want action, and the most effective possible action taken, to lower prescription drug prices.” “It is the height of hypocrisy for Kurt Schrader to take credit for the bill that came out of the House on drug pricing and is now before the Senate when his principal contribution to that bill was to do everything in his power to weaken it,” said David Mitchell, president of the group Patients for Affordable Drugs. Schrader’s sleight of hand reflects the enduring influence of the biopharmaceutical industry in the Democratic Party, and the difficulty in exposing the sometimes complex ways that politicians advance the industry’s interests. And while Schrader portrays himself as a critic of “big money in politics,” Big Pharma has stepped in with major financial support for Schrader’s bid as he seeks to fend off progressive primary challenger Jamie McLeod-Skinner in Oregon’s 5th Congressional District. He played a key role in watering down Democrats’ efforts to rein in prescription drug prices. But Schrader is not being completely honest about his record on prescription drug price policy.
0 Comments
Leave a Reply. |